Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.4 HKD | -.--% | +3.65% | -19.76% |
25/04 | Simcere Pharmaceutical’ Profit Down 23% in 2023 | MT |
10/04 | Simcere Pharmaceutical's Cancer Drug Gets Fast Track Designation From US FDA | MT |
Business Summary
Number of employees: 7,027
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| - | - | 7,302 | 100.0 % | - |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 7,348 | 100.0 % | 7,302 | 100.0 % | -0.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jin Sheng Ren
CEO | Chief Executive Officer | 61 | 01/95/01 |
Yu Shan Wan
DFI | Director of Finance/CFO | 53 | 01/00/01 |
Gaobo Zhou
CIO | Chief Investment Officer | 45 | 17/22/17 |
Chief Tech/Sci/R&D Officer | 62 | 01/22/01 | |
Pin Wang
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/19/01 |
Peng Wang
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/09/01 |
Xi Wang
BRD | Director/Board Member | 41 | 01/20/01 |
Ren Hong Tang
BRD | Director/Board Member | 44 | 01/19/01 |
Ying Guo
IRC | Investor Relations Contact | - | - |
Danny Chen
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jin Sheng Ren
CEO | Chief Executive Officer | 61 | 01/95/01 |
Xin Hua Wang
BRD | Director/Board Member | 69 | 19/19/19 |
Yu Shan Wan
DFI | Director of Finance/CFO | 53 | 01/00/01 |
Rui Lin Song
BRD | Director/Board Member | 61 | 19/19/19 |
Jian Guo Wang
BRD | Director/Board Member | 64 | 19/19/19 |
Ren Hong Tang
BRD | Director/Board Member | 44 | 01/19/01 |
Ka Woon Sung
BRD | Director/Board Member | 53 | 18/23/18 |
Xi Wang
BRD | Director/Board Member | 41 | 01/20/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,609,761,618 | 749,085,004 ( 28.70 %) | 0 | 28.70 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
3D MEDICINES INC. 8.93% | 23,047,468 | 8.93% | 17,757,152 $ |
Company contact information
Simcere Pharmaceutical Group Ltd.
No. 699-18 Xuan Wu Avenue Xuan Wu District
210042, Nanjing
+86 25 8556 6666
http://www.simcere.comSector
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.76% | 1.77B | |
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+12.33% | 13.54B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B |
- Stock Market
- Equities
- 2096 Stock
- Company Simcere Pharmaceutical Group Limited